Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frailty is associated with poorer health-related quality of life among adult heart transplant recipients: a cross-sectional study.

BMC cardiovascular disorders·2026
Same author

Influence of diet on the modulation of gut microbiota and its neurobiological effects on cognition: a systematic review and meta-analysis.

Food & nutrition research·2026
Same author

Well-being and the invisible role of the family in patients with heart failure.

Revista espanola de cardiologia (English ed.)·2026
Same author

Experience and outcomes of kidney transplantation in a Colombian referral center.

Frontiers in nephrology·2026
Same author

Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy.

Frontiers in oncology·2026
Same author

Clinical characteristics and real-world survival in acral melanoma: experience from a comprehensive cancer center in Latin America.

Frontiers in oncology·2026

Related Experiment Video

Updated: Jan 13, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.3K

Perfusionist's role in long-term ventricular assist device.

Yolly Gigliola Perea Bautista1, Yadira Estrada García2, Dafna García Gómez3

  • 1Vascular Nursing and Perfusion Department, Hospital Internacional de Colombia - Instituto Cardiovascular, Floridablanca, Colombia.

Perfusion
|January 6, 2026
PubMed
Summary

This study details the perfusion protocol for left ventricular assist device (LVAD) implantation in advanced heart failure patients. Optimal intraoperative management by perfusionists is crucial for successful outcomes.

Keywords:
anesthesiacardiac proceduresextracorporeal circulationheart failureheart-assist devicesperfusion

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K

Related Experiment Videos

Last Updated: Jan 13, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.3K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Perfusion Science

Background:

  • Ventricular assist devices (VADs) are critical for managing advanced heart failure (Stage D).
  • Perfusionists play a vital role in VAD implantation, ensuring hemodynamic stability and oxygen delivery.
  • Standardized protocols are essential for successful VAD procedures.

Purpose of the Study:

  • To describe the institutional perfusion protocol for left ventricular assist device (LVAD) implantation.
  • To characterize intraoperative perfusion parameters during LVAD procedures at a Latin American center.

Main Methods:

  • Retrospective observational cohort study.
  • Inclusion of all patients undergoing LVAD implantation at a Colombian referral center.
  • Descriptive statistical analysis of intraoperative data.

Main Results:

  • 33 patients underwent LVAD implantation; median age 54 years, 51.52% male.
  • Ischemic cardiomyopathy was the most common etiology (27.27%).
  • Median cardiopulmonary bypass time was 153 minutes, with median lactate levels of 1.8 mmol/L and cardiac index between 2.3-2.6 L/min/m².

Conclusions:

  • Cardiopulmonary perfusion is vital for successful long-term LVAD implantation in advanced heart failure.
  • Optimal intraoperative management, including controlled temperature, low lactate, and appropriate cardiac index, is essential.
  • Standardized strategies and perfusionist expertise are critical for advanced heart failure management with LVADs.